{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lenexa",
      "state": "KS",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "87830",
      "recalling_firm": "Remel Inc",
      "address_1": "12076 Santa Fe Trail Dr",
      "address_2": "",
      "postal_code": "66215-3519",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "US Nationwide distribution in the states of AZ, CA, CO, CT, GA, IA, IL, IN, MA, MI, MN, MO, NC, ND, OH, OR, PA, SD, TN, TX, and VA.  There was government distribution and no military or foreign distribution.",
      "recall_number": "Z-1561-2021",
      "product_description": "Remel Bile Esculin Azide Agar w/ 6mcg/ml Vancomycin, Product #R01186, 10/package - Product Usage:  use in qualitative procedures as a screening method for primary isolation and presumptive identification of vancomycin-resistance enterococci (VRE) from surveillance cultures.",
      "product_quantity": "91/10-test units",
      "reason_for_recall": "The media allows growth of E. faecalis ATCC 29212 with blackening of the media.",
      "recall_initiation_date": "20210422",
      "center_classification_date": "20210512",
      "termination_date": "20230808",
      "report_date": "20210519",
      "code_info": "Lot #248035, Exp. 2021-04-27",
      "more_code_info": ""
    }
  ]
}